Screener
OnKure Therapeutics, Inc. OKUR EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206345
FAQ
- What is OnKure Therapeutics, Inc.'s EPS (diluted)?
- OnKure Therapeutics, Inc. (OKUR) reported EPS (diluted) of -$1.11 in Q1 2026.
- How has OnKure Therapeutics, Inc.'s EPS (diluted) changed year-over-year?
- OnKure Therapeutics, Inc.'s EPS (diluted) increased by 6.7% year-over-year, from -$1.19 to -$1.11.
- What is the long-term trend for OnKure Therapeutics, Inc.'s EPS (diluted)?
- Over 3 years (2021 to 2025), OnKure Therapeutics, Inc.'s EPS (diluted) has grown at a -2.8% compound annual growth rate (CAGR), from -$4.80 to -$4.41.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about OnKure Therapeutics, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude